GGrantIndex
Sort

64,565 grants matching drug discovery

RADIOTRACER R &D IN NUCLEAR MEDICINE AND NEUROSCIENCES

$653,199
Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2001 · NS

Role of SCN1B in Inherited Epilepsy

$653,145
Lori L Isom · University Of Michigan At Ann Arbor · R37 · FY2019 · NS

Role of SCN1B in Inherited Epilepsy

$653,145
Lori L Isom · University Of Michigan At Ann Arbor · R37 · FY2020 · NS

Genetic Variation and Evolution of Artemisinin Resistance

$653,119
Dyann F Wirth · Harvard School Of Public Health · R01 · FY2016 · AI

Genetic and Functional Analysis of Rapid Renal Decline in Diabetes: A Family-based Approach to Accelerate Gene Discovery

$653,066
Marcus Guy Pezzolesi · University Of Utah · R01 · FY2023 · DK

Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD

$653,024
Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2020 · NS

Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD

$653,024
Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2019 · NS

Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations

$652,987
Charles Darkoh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AI

Biosynthesis And Function Of Lipopolysaccharides

$652,932
Pei Zhou · Duke University · R01 · FY2012 · GM

Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance

$652,918
John Adams · University Of South Florida · R01 · FY2024 · AI

Biosynthesis And Function Of Lipopolysaccharides

$652,865
Pei Zhou · Duke University · R01 · FY2011 · GM

Alzheimer Disease Genetic Architecture in African Americans

$652,832
Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2015 · AG

Intervention Core for the Dietary Biomarkers Development Center at Harvard University

$652,800
Frank M Sacks · Harvard School Of Public Health · U2C · FY2023 · DK

The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation

$652,797
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2023 · AR

Heartland Institute for Clinical and Translational Research

$652,585
Richard J. Barohn · University Of Kansas Medical Center · KL2 · FY2011 · RR

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity

$652,565
Susan G Dorsey · University Of Maryland Baltimore · R01 · FY2012 · NR

Cell-Based HTS Campaign to Identify Negative Allosteric Modulators of the Leukemia-associated Tyrosine Kinase, BTK”.

$652,558
Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

A Vector-free Intracellular Delivery Platform for Drug Discovery

$652,538
Jonathan Brian Gilbert · Sqz Biotechnologies Company, Inc. · R44 · FY2016 · GM

Non Alcoholic Steatohepatitis Clinical Research Network

$652,507
Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2020 · DK

Defining the Role of Host Factors in Ebola Virus RNA Synthesis

$652,503
Douglas J. Lacount · Washington University · P01 · FY2018 · AI

Vitamin C (ascorbic acid) recommended dietary ingestion

$652,454
Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Developing antiviral agents that inhibit HCV translation

$652,409
Ptc Therapeutics, Inc. · R44 · FY2004 · AI

Developing antiviral agents that inhibit HCV translation

$652,409
Ptc Therapeutics, Inc. · R44 · FY2005 · AI

Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance

$652,398
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2021 · CA

Immobilized Proteins In Drug Discovery

$652,389
Josephine Earley · National Institute On Aging · ZIA · FY2020 · AG